India, the world’s capital of diabetes, has an escalating diabetes epidemic. Diabetes, a non-communicable disease, affects about 8.7% Indians today, and this number is predicted to hit 70 million by 2025 and 80 million by 2030. Although the exact reasons for this rapid rise in diabetes in the country are not yet clear, experts blame it on multiple factors. In a recent study, researchers from the USA, Germany and India have investigated the status of diabetic care among Indian adults. The findings, published in the journal BMC Medicine, present a grim picture of diabetes management in different states and socio-demographic groups in India.
You are here
Researchers from the Institute of Public Health (IPH), Bangalore, with the support of the Alliance for Health Policy and Systems Research of the World Health Organization, have assessed the quality of generic medicine and their branded equivalents in South India. Their results show that the quality of generic medicines from multiple sources was similar to that of the branded medicines.
Recent study shows that chronic illnesses might be shared with the members of a household. A team of public health professionals from from various universities in India and the USA have studied 2,574 households during 2013 and 2014, to understand the prevalence and stage of diagnosis of five chronic diseases.